Carazolol
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATCvet code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.055.387 |
Chemical and physical data | |
Formula | C18H22N2O2 |
Molar mass | 298.386 g·mol−1 |
3D model (JSmol) | |
|
Carazolol is a high affinity inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]
References
[edit]- ^ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.
External links
[edit]- Carazolol at the U.S. National Library of Medicine Medical Subject Headings (MeSH)